Statistical analysis
Development indicators from each participating country were obtained from the World Bank Open Data platform6. Data on COVID-19 incidence and mortality beginning on February 28, 2020 (first COVID-19 case diagnosed in LATAM) to April 30, 2021 (day the last survey closed) was extracted from the data repository for the 2019 Novel Coronavirus Visual Dashboard operated by the Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE).14
Respondent characteristics were reported using descriptive statistics. Categorical variables were assessed by chi-square test. Univariate and multivariable logistic analysis was done for the following health care factors: treatment of new patients, treatment of active/ongoing cases, suspension of outpatient procedures, suspension of oncologic surgeries, suspension of radiation therapy sessions, suspension of stem cell transplant (SCT) and suspension of surveillance consultations. We calculated crude odds ratios and variables associated with significant impact in a multivariable logistic regression analysis.
Radiation therapy sessions and SCT proportions were calculated based on the total number of participants that reported having access to radiation therapy or SCT. Participants who reported no access to those services or answered ”Do not know” were excluded. Significance was established when p values were less than 0.05. Statistical analyses were performed using RStudio version 1.2.1335.